At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

This article is authored by Dr Joy John Mammen, professor, Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore.

RNA modifications have emerged as a pivotal area of focus in molecular biology and precision medicine. Recent breakthroughs highlight the dynamic nature of ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical ...

Company secures $5M in funding to accelerate its rapid testing platformUSP<1223> Validation achieved, reinforcing 20-hour testing ...

The accreditation allows EXALTA to perform microbiology testing in-house rather than relying on external partners.

A collaboration of scientists at the University of Manchester and the University of Birmingham has explored a more effective ...

Xcovery Holdings, Inc. (Xcovery), an evidence-based, innovation-driven pharmaceutical company, today announced an agreement ...

Researchers developed STRIPE, a targeted long-read RNA sequencing tool that identifies disease-causing variants missed by ...

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

The CURE-ND initiative was created in 2020 as a strategic partnership across leading European research institutes. CURE-ND brings together four leading national institutes (the Deutsches Zentrum für ...